Skip to main content

Advertisement

Log in

Is it time to spit? More evidence for the oral–gut–liver axis in liver disease

  • Editorial
  • Published:
Hepatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol 2020;72:558–577

    Article  CAS  Google Scholar 

  2. Bajaj JS, Betrapally NS, Hylemon PB, et al. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy. Hepatology 2015;62:1260–1271

    Article  CAS  Google Scholar 

  3. Acharya C, Sahingur SE, Bajaj JS. Microbiota, cirrhosis, and the emerging oral-gut-liver axis. JCI Insight. 2017. https://doi.org/10.1172/jci.insight.94416.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kummen M, Holm K, Anmarkrud JA, et al. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls. Gut 2017;66:611–619

    Article  Google Scholar 

  5. Ruhlemann M, Liwinski T, Heinsen FA, et al. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis. Aliment Pharmacol Ther 2019;50:580–589

    Article  Google Scholar 

  6. Weismuller TJ, Trivedi PJ, Bergquist A, et al. Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology 2017;152:1975–1984 (e8)

    Google Scholar 

  7. Horvath A, Rainer F, Bashir M, et al. Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis. Sci Rep 2019;9:12000

    Article  Google Scholar 

  8. Lapidot Y, Amir A, Ben-Simon S, et al. Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis. Hepatol Int. 2020. https://doi.org/10.1007/s12072-020-10089-z.

    Article  PubMed  Google Scholar 

  9. Rothschild D, Weissbrod O, Barkan E, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 2018;555:210–215

    Article  CAS  Google Scholar 

  10. Bajaj JS, Torre A, Rojas ML, et al. Cognition and hospitalizations are linked with salivary and faecal microbiota in cirrhosis cohorts from the USA and Mexico. Liver Int. 2020;40(6):1395–407.

    Article  Google Scholar 

Download references

Acknowledgements

Funding was provided by Office of Research and Development (Grant no. I0CX001076), National Center for Advancing Translational Sciences (Grant nos. R21TR002024, R21TR003095).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jasmohan S. Bajaj.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Acharya, C., Bajaj, J.S. Is it time to spit? More evidence for the oral–gut–liver axis in liver disease. Hepatol Int 15, 4–5 (2021). https://doi.org/10.1007/s12072-021-10136-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-021-10136-3

Keywords

Navigation